Evidence map›Paper›PMID 33926096›Full record

ArticleInternational journal of molecular sciences2021

Cell Lysis Directed by SulA in Response to DNA Damage in

Masayuki Murata, Keiko Nakamura, Tomoyuki Kosaka, Natsuko Ota, Ayumi Osawa, Ryunosuke Muro, Kazuya Fujiyama, Taku Oshima, Hirotada Mori, Barry L Wanner and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masayuki MurataLife Science, Graduate School of Science and Technology for Innovation, Yamaguchi University, Ube 755-8611, Japan.
Keiko NakamuraApplied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan.
Tomoyuki KosakaLife Science, Graduate School of Science and Technology for Innovation, Yamaguchi University, Ube 755-8611, Japan.
Natsuko OtaLife Science, Graduate School of Science and Technology for Innovation, Yamaguchi University, Ube 755-8611, Japan.
Ayumi OsawaLife Science, Graduate School of Science and Technology for Innovation, Yamaguchi University, Ube 755-8611, Japan.
Ryunosuke MuroApplied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan.
Kazuya FujiyamaApplied Molecular Bioscience, Graduate School of Medicine, Yamaguchi University, Ube 755-8505, Japan.
Taku OshimaDepartment of Biotechnology, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan.
Hirotada MoriGraduate School of Information Science, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0192, Japan.ORCID 0000-0003-3855-778X
Barry L WannerDepartment of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
Mamoru YamadaLife Science, Graduate School of Science and Technology for Innovation, Yamaguchi University, Ube 755-8611, Japan.ORCID 0000-0003-4354-7324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SOS response is induced upon DNA damage and the inhibition of Z ring formation by the product of the

Indexed as

AmidohydrolasesApoptosisBacterial ProteinsCell DivisionDNA DamageEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialGenes, BacterialSerine EndopeptidasesTrans-ActivatorsAmidohydrolasesBacterial ProteinsEscherichia coli ProteinsSerine EndopeptidasesSoxS protein, E colisulA protein, E coliTrans-ActivatorsUDP-3-O-acyl-N-acetylglucosamine deacetylasecell lysisDNA damageLpxCSoxSSulA

Identifiers

PMID33926096
PMCPMC8123628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.